It may be related to atherosclerosis and cardiovascular comorbidity associated with T2D, however, because miR-151 may inhibit the apoptosis of endothelial cells in atherosclerosis and target IL-17A [31]. Here, IL17A is linked to type 2 diabetes mellitus.